Table 2.
Variable | Summary estimates | |||
---|---|---|---|---|
Mean (standard deviation) | p-value | aOR [95% CI] | ||
CCR5-tropic (FPR > 3.5) | CXCR4-tropic (FPR ≤ 3.5) | |||
Markers of immune activation | ||||
CD4+ T cell count (cells/µl)a | 199 (225) | 126 (216) | 0.02 | 0.89 [0.80–0.99] |
CD8+ T cell count (10log cells/µl)a | 119 (156) | 158 (105) | 0.11 | NA |
CD38+ (% in CD4+ T cells) | 58.5 (17.4) | 62.0 (14.7) | 0.87 | NA |
HLA-DR+ (% in CD4+ T cells)a | 14.4 (14.6) | 26.6 (25.4) | 0.01 | 1.12 [0.91–1.36] |
HLA-DR+ CD38+ (% in CD4+ T cells)a | 7.3 (6.1) | 12.0 (16.8) | 0.03 | 0.99 [0.79–1.22] |
CD70 (% in CD4+ T cells)a | 1.1 (2.1) | 2.0 (6.0) | 0.08 | 0.98 [0.86–1.11] |
HLA-DR+CD38+ (% in CD8+ T cells)a | 22.7 (13.3) | 15.6 (14.7) | 0.52 | NA |
CD57+ (% in CD4+ T cells) | 45.6 (16.7) | 39.3 (14.3) | 0.41 | NA |
CD169 (% in classical monocytes) | 93.0 (35.5) | 96.6 (20.1) | 0.05 | 0.97 [0.84–1.11] |
Central memory T cell (% of CD4+ T cells) | 27.8 (13.4) | 26.6 (10.0) | 0.95 | NA |
TNFR2 (pg/ml)a | 1,931 (1,226) | 1,806 (809) | 0.24 | NA |
sCD163 (pg/ml)a | 383.4 (7,527.7) | 34.6 (1,924.2) | 0.49 | NA |
Receptor-ligand interactions | ||||
CCR5+ CXCR4+ (% in CD4+ T cells)a | 5.5 (17.8) | 6.4 (34.6) | 0.20 | NA |
CCL3 (MIP-1⍺) (pg/ml)a | 103.9 (116.1) | 103.6 (72.6) | 0.91 | NA |
CCL4 (MIP-1β) (pg/ml)a | 57.3 (45.4) | 65.1 (37.0) | 0.95 | NA |
CCL5 (RANTES) (pg/ml)a | 30,445 (95,015) | 35,019 (179,839) | 0.17 | NA |
CXCL12 (SDF-1⍺) (pg/ml)a | 35.5 (824.8) | 88.7 (2,014.2) | 0.82 | NA |
CXCL10 (IP-10) (pg/ml)a | 510.3 (816.3) | 556.3 (259.1) | 0.68 | NA |
IL-7 (pg/ml)a | 117.3 (52.7) | 106.9 (91.7) | 0.92 | NA |
Units are displayed in italics.
aOR adjusted odds ratio, FPR false-positive rate, 95% CI 95% confidence interval.
P-values below 0.05 are displayed in bold.
aData was log-transformed, means are log-corrected, standard deviation is original. p-value derived from unpaired t-test of (log-transformed) data.